Evidence map›Paper›PMID 33514426›Full record

ArticleArthritis research & therapy2021

The spectrum of association in HLA region with rheumatoid arthritis in a diverse Asian population: evidence from the MyEIRA case-control study.

Lay Kim Tan, Chun Lai Too, Lina Marcela Diaz-Gallo, Sulaiman Wahinuddin, Ing Soo Lau, Hussein Heselynn, Shahril Nor-Shuhaila, Suk Chyn Gun, Mageswaran Eashwary, Mohamed Said Mohd-Shahrir and 7 more

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Association ofRheumatology and immunology research · 2025
    Article
  5. Review
  6. Frontiers in immunology · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Genetics of rheumatoid arthritis.Seminars in immunopathology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Lay Kim TanImmunogenetic Unit, Allergy and Immunology Research Center, Ministry of Health Malaysia, Institute for Medical Research, National Institutes of Health Complex, Shah Alam, Selangor, Malaysia. tanlk@moh.gov.my.ORCID 0000-0001-5846-2783
Chun Lai TooImmunogenetic Unit, Allergy and Immunology Research Center, Ministry of Health Malaysia, Institute for Medical Research, National Institutes of Health Complex, Shah Alam, Selangor, Malaysia. toocl@moh.gov.my.
Lina Marcela Diaz-GalloDepartment of Medicine, Division of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Sulaiman WahinuddinFaculty of Medicine, Universiti Kuala Lumpur Royal College of Medicine Perak, Ipoh, Perak, Malaysia.
Ing Soo LauDepartment of Medicine, Ministry of Health Malaysia, Selayang Hospital, Selayang, Selangor, Malaysia.
Hussein HeselynnDepartment of Medicine, Ministry of Health Malaysia, Putrajaya Hospital, Putrajaya, Malaysia.
Shahril Nor-ShuhailaDepartment of Medicine, Ministry of Health Malaysia, Putrajaya Hospital, Putrajaya, Malaysia.
Suk Chyn GunDepartment of Medicine, Ministry of Health Malaysia, Hospital Tuanku Ja'afar Seremban, Seremban, Negeri Sembilan, Malaysia.
Mageswaran EashwaryDepartment of Medicine, Ministry of Health Malaysia, Putrajaya Hospital, Putrajaya, Malaysia.
Mohamed Said Mohd-ShahrirFaculty of Medicine, Universiti Kebangsaan Malaysia Medical Center, Kuala Lumpur, Malaysia.
Mohd Mokhtar AinonDepartment of Medicine, Ministry of Health Malaysia, Tengku Ampuan Afzan Hospital, Kuantan, Pahang, Malaysia.
Rosman AzmillahDepartment of Medicine, Ministry of Health Malaysia, Selayang Hospital, Selayang, Selangor, Malaysia.
Othman MuhainiDepartment of Medicine, Ministry of Health Malaysia, Hospital Raja Perempuan Bainun, Ipoh, Perak, Malaysia.
Murad ShahnazMinistry of Health Malaysia, Federal Government Administrative Center, Putrajaya, Malaysia.
Lars AlfredssonInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Lars KlareskogFaculty of Medicine, Universiti Kuala Lumpur Royal College of Medicine Perak, Ipoh, Perak, Malaysia.
Leonid PadyukovDepartment of Medicine, Division of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. leonid.padyukov@ki.se.
Ministry of Health · MYKarolinska University Hospital · SEKarolinska Institutet · SEUniversity Kebangsaan Malaysia Medical Centre · MYUniversity of Kuala Lumpur · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFine-mapping of human leukocyte antigen (HLA) region for rheumatoid arthritis (RA) risk factors has identified several HLA alleles and its corresponding amino acid residues as independent signals (i.e., HLA-A, HLA-B, HLA-DPB1, and HLA-DQA1 genes), in addition to the well-established genetic factor in HLA-DRB1 gene. However, this was mainly performed in the Caucasian and East Asian populations, and data from different Asian regions is less represented. We aimed to evaluate whether there are independent RA risk variants in both anti-citrullinated protein antibody (ACPA)-positive and ACPA-negative RA patients from the multi-ethnic Malaysian population, using the fine-mapping of HLA region strategy.

methodsWe imputed the classical HLA alleles, amino acids, and haplotypes using the Immunochip genotyping data of 1260 RA cases (i.e., 530 Malays, 259 Chinese, 412 Indians, and 59 mixed ethnicities) and 1571 controls (i.e., 981 Malays, 205 Chinese, 297 Indians, and 87 mixed ethnicities) from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA) population-based case-control study. Stepwise logistic regression was performed to identify the independent genetic risk factors for RA within the HLA region.

resultsWe confirmed that the HLA-DRB1 amino acid at position 11 with valine residue conferred the strongest risk effect for ACPA-positive RA (OR = 4.26, 95% CI = 3.30-5.49, P

conclusionsOur results demonstrate that the RA-associated genetic factors in the multi-ethnic Malaysian population are similar to those in the Caucasian population, despite significant differences in the genetic architecture of HLA region across populations. A novel and distinct independent association between the HLA-DQB1*03:02 allele and ACPA-positive RA was observed in the Malays. In common with the Caucasian population, there is little risk from HLA region for ACPA-negative RA.

Indexed as

Arthritis, RheumatoidAllelesAutoantibodiesCase-Control StudiesGenetic Predisposition to DiseaseHLA AntigensHLA-DRB1 ChainsHumansAutoantibodiesHLA AntigensHLA-DRB1 ChainsHLA amino acid residuesHLA fine-mappingMulti-ethnic Malaysian populationRheumatoid arthritisRisk variants

Identifiers

PMID33514426
PMCPMC7847037
OpenAlexW3125459962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.